{"disease":{"id":"advanced-thymic-epithelial-tumor","name":"advanced thymic epithelial tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03193437","title":"Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Georgetown University","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}